BioCorRx Market Risk Adjusted Performance
| BICX Stock | | | USD 0.40 0.00 0.00% |
Technical inputs supporting the Market Risk Adjusted Performance indicator for BioCorRx are shown here. Values are derived from historical price and volume observations. BioCorRx has a market cap of 11.82 M, operating margin of -33.51%. For allocation context, review
Trending Equities. Portfolio positioning is summarized for reference. A position in BioCorRx appears within the mix. The position is captured in the allocation summary. The relative size of each holding follows the allocation framework. All metrics are derived from available inputs and shown for reference. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as
signals in discontinued.
BioCorRx has current Market Risk Adjusted Performance of 1.11.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 1.11 | |
| ER[a] | = | Expected return on investing in BioCorRx |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
BioCorRx is rated
fifth in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
112.31 of Maximum Drawdown per Market Risk Adjusted Performance. At
112.31 , BioCorRx's Maximum Drawdown-to-Market Risk Adjusted Performance multiple reflects the spread between these metrics
Compare BioCorRx to Peers
Other Technical Indicators